Mineralys Therapeutics reports GAAP loss of $0.64 per share, missing by $0.09

Summary

Mineralys Therapeutics posted GAAP earnings per share of -$0.64, missing by $0.09, according to a Seeking Alpha headline published November 4, 2026. The source item carried only a headline, so it gives no reporting period, revenue figures, or the expectations used for the comparison.

Timeline

1. Seeking Alpha

   4 Nov 2026, 22:58 UTCSource ↗

   Seeking Alpha reports that Mineralys Therapeutics posted GAAP EPS of -$0.64, missing by $0.09.